Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Vaccines

Free Subscription Articles published in MMWR Morb Mortal Wkly Rep Retrieve available abstracts of 71 articles: HTML format

Single Articles

November 2025
1. OLMSTED KE, Ramsey-Omonua T, Thomas ES, Lee JT, et al
   Notes from the Field: Expanding Birthing Hospital Enrollment in the Vaccines for Children Program to Increase Infant Immunization Against Respiratory Syncytial Virus - United States, October 2023-March 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:589-591.
   PubMed     Abstract available
   
   
   September 2025
2. RUSS S, Nogareda F, Regan AK, Benedetti E, et al
   Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:570-578.
   PubMed     Abstract available
   
   
   
3. REINHART K, Huang S, Kniss K, Reed C, et al
   Influenza-Associated Pediatric Deaths - United States, 2024-25 Influenza Season.
   MMWR Morb Mortal Wkly Rep. 2025;74:565-569.
   PubMed     Abstract available
   
   
   
4. FAZAL A, Harker EJ, Neelam V, Olson SM, et al
   Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season.
   MMWR Morb Mortal Wkly Rep. 2025;74:556-564.
   PubMed     Abstract available
   
   
   
5. O'HALLORAN A, Habeck JW, Gilmer M, Threlkel R, et al
   Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.
   MMWR Morb Mortal Wkly Rep. 2025;74:529-537.
   PubMed     Abstract available
   
   
   August 2025
6. MOULIA DL, Link-Gelles R, Chu HY, Jamieson D, et al
   Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:508-514.
   PubMed     Abstract available
   
   
   
7. GROHSKOPF LA, Blanton LH, Ferdinands JM, Reed C, et al
   Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season.
   MMWR Morb Mortal Wkly Rep. 2025;74:500-507.
   PubMed     Abstract available
   
   
   
8. BOUNDY EO, Fast H, Jatlaoui TC, Razzaghi H, et al
   Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024.
   MMWR Morb Mortal Wkly Rep. 2025;74:484-489.
   PubMed     Abstract available
   
   
   
9. PINGALI C, Yankey D, Elam-Evans LD, Trahan A, et al
   Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2024.
   MMWR Morb Mortal Wkly Rep. 2025;74:466-472.
   PubMed     Abstract available
   
   
   
10. RODRIGUEZ RM, Torres JR, Chinnock B, Kean E, et al
    Emergency Department Survey of Vaccination Knowledge, Vaccination Coverage, and Willingness to Receive Vaccines in an Emergency Department Among Underserved Populations - Eight U.S. Cities, April-December, 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:456-462.
    PubMed     Abstract available
    
    
    June 2025
11. RAO AK, Minhaj FS, Carter RJ, Duffy J, et al
    Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged >/=18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2025;74:385-392.
    PubMed     Abstract available
    
    
    May 2025
12. LEBO E, Vynnycky E, Alexander JP Jr, Ferrari MJ, et al
    Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction - 19 Countries, 2019-2055.
    MMWR Morb Mortal Wkly Rep. 2025;74:305-311.
    PubMed     Abstract available
    
    
    
13. PATTON ME, Moline HL, Whitaker M, Tannis A, et al
    Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:273-281.
    PubMed     Abstract available
    
    
    April 2025
14. MATHIS AD, Raines K, Filardo TD, Wiley N, et al
    Measles Update - United States, January 1-April 17, 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:232-238.
    PubMed     Abstract available
    
    
    March 2025
15. HUSEYNOV S, Saxentoff E, Diedrich S, Martin J, et al
    Notes from the Field: Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater - Five European Countries, September-December 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:122-124.
    PubMed    
    
    
    February 2025
16. FRUTOS AM, Cleary S, Reeves EL, Ahmad HM, et al
    Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:83-90.
    PubMed     Abstract available
    
    
    
17. GARGANO JW, Stefanos R, Dahl RM, Castilho JL, et al
    Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008-2022.
    MMWR Morb Mortal Wkly Rep. 2025;74:96-101.
    PubMed     Abstract available
    
    
    
18. LINK-GELLES R, Chickery S, Webber A, Ong TC, et al
    Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged >/=18 Years - VISION and IVY Networks, September 2024-January 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:73-82.
    PubMed     Abstract available
    
    
    January 2025
19. KOBAYASHI M, Leidner AJ, Gierke R, Xing W, et al
    Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged >/=50 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:1-8.
    PubMed     Abstract available
    
    
    December 2024
20. SCHILLIE S, Loehr J, Chen WH, Moser CA, et al
    New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, October 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1124-1128.
    PubMed     Abstract available
    
    
    
21. HARDY CM, Rathee M, Chaudhury S, Wadood MZ, et al
    Progress Toward Poliomyelitis Eradication - Afghanistan, January 2023-September 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1129-1134.
    PubMed     Abstract available
    
    
    
22. SANDUL AL, Rapposelli K, Nyendak M, Kim M, et al
    Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19-59 Years - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1106.
    PubMed     Abstract available
    
    
    November 2024
23. RESES HE, Segovia G, Dubendris H, Barbre K, et al
    Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1052-1057.
    PubMed     Abstract available
    
    
    
24. KRISS JL, Black CL, Razzaghi H, Meghani M, et al
    Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1044-1051.
    PubMed     Abstract available
    
    
    
25. STEFANOS R, Schatzman S, Wakeman B, Raines K, et al
    Pediatric Rash Illness Outbreak with Initial Positive Measles Immunoglobulin M Antibody Test Results - American Samoa, March-July 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:1030-1035.
    PubMed     Abstract available
    
    
    
26. MINTA AA, Ferrari M, Antoni S, Lambert B, et al
    Progress Toward Measles Elimination - Worldwide, 2000-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:1036-1042.
    PubMed     Abstract available
    
    
    October 2024
27. SUN J, Zhang Y, Zhou S, Song Y, et al
    Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period - Suzhou City, Jiangsu Province, China, 2018-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:958-964.
    PubMed     Abstract available
    
    
    
28. JONES CE, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, et al
    Routine Vaccination Coverage - Worldwide, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:978-984.
    PubMed     Abstract available
    
    
    
29. BELL J, Meng L, Barbre K, Wong E, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2023-24 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2024;73:966-972.
    PubMed     Abstract available
    
    
    
30. STEIN SR, Beron AJ, Nelson KM, Price E, et al
    Notes from the Field: Enhanced Surveillance for Raccoon Rabies Virus Variant and Vaccination of Wildlife for Management - Omaha, Nebraska, October 2023-July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:933-935.
    PubMed     Abstract available
    
    
    
31. NAMAGEYO-FUNA A, Greene SA, Henderson E, Traore MA, et al
    Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:909-916.
    PubMed     Abstract available
    
    
    
32. SEITHER R, Yusuf OB, Dramann D, Calhoun K, et al
    Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2023-24 School Year.
    MMWR Morb Mortal Wkly Rep. 2024;73:925-932.
    PubMed     Abstract available
    
    
    
33. ZENO EE, Nogareda F, Regan A, Couto P, et al
    Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:861-868.
    PubMed     Abstract available
    
    
    September 2024
34. HAVERS FP, Whitaker M, Chatwani B, Patton ME, et al
    COVID-19-Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months - COVID-NET, 12 States, October 2022-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:830-836.
    PubMed     Abstract available
    
    
    
35. HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
    Decline in Vaccination Coverage by Age 24 Months and Vaccination Inequities Among Children Born in 2020 and 2021 - National Immunization Survey-Child, United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:844-853.
    PubMed     Abstract available
    
    
    
36. RAZZAGHI H, Garacci E, Kahn KE, Lindley MC, et al
    Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:837-843.
    PubMed     Abstract available
    
    
    
37. TIPPINS A, Boyd EM, Coy KC, Mutamba G, et al
    Vaccination Coverage by Age 24 Months Among Children Born During 2017-2021 - U.S.-Affiliated Pacific Islands.
    MMWR Morb Mortal Wkly Rep. 2024;73:854-859.
    PubMed     Abstract available
    
    
    
38. PANAGIOTAKOPOULOS L, Moulia DL, Godfrey M, Link-Gelles R, et al
    Use of COVID-19 Vaccines for Persons Aged >/=6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025.
    MMWR Morb Mortal Wkly Rep. 2024;73:819-824.
    PubMed     Abstract available
    
    
    
39. COLLINS JP, Loehr J, Chen WH, Clark M, et al
    Use of Haemophilus influenzae Type b-Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:799-802.
    PubMed     Abstract available
    
    
    
40. MBAEYI C, Ul Haq A, Safdar RM, Khan Z, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2023-June 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:788-792.
    PubMed     Abstract available
    
    
    
41. KOBAYASHI M, Leidner AJ, Gierke R, Farrar JL, et al
    Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:793-798.
    PubMed     Abstract available
    
    
    August 2024
42. VALIER MR, Yankey D, Elam-Evans LD, Chen M, et al
    Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:722-730.
    PubMed     Abstract available
    
    
    
43. PINGALI C, Yankey D, Chen M, Elam-Evans LD, et al
    National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:708-714.
    PubMed     Abstract available
    
    
    
44. TIPPINS A, Mutamba G, Boyd EM, Coy KC, et al
    Human Papillomavirus Vaccination Coverage Among Adolescent Girls Aged 13-17 Years - U.S.-Affiliated Pacific Islands, 2013-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:715-721.
    PubMed     Abstract available
    
    
    
45. FREEDMAN MS, Swisher SD, Wallace RM, Laughlin ME, et al
    Notes from the Field: Heightened Precautions for Imported Dogs Vaccinated with Potentially Ineffective Rabies Vaccine - United States, August 2021-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:706-707.
    PubMed    
    
    
    
46. BRITTON A, Roper LE, Kotton CN, Hutton DW, et al
    Use of Respiratory Syncytial Virus Vaccines in Adults Aged >/=60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:696-702.
    PubMed     Abstract available
    
    
    
47. ZHOU F, Jatlaoui TC, Leidner AJ, Carter RJ, et al
    Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:682-685.
    PubMed     Abstract available
    
    
    
48. TOHME RA, Shadaker S, Adamia E, Khonelidze I, et al
    Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:660-666.
    PubMed     Abstract available
    
    
    July 2024
49. ALLEMAN MM, Sereno LS, Whittembury A, Li X, et al
    Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:648-655.
    PubMed     Abstract available
    
    
    June 2024
50. MENDES A, Mohamed GA, Derow M, Stehling-Ariza T, et al
    Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:575-580.
    PubMed     Abstract available
    
    
    
51. ADEGOKE OJ, Rachlin A, Porter AM, Katsande R, et al
    Migration from Epi Info to District Health Information Software 2 for Vaccine-Preventable Disease Surveillance - World Health Organization African Region, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:529-533.
    PubMed     Abstract available
    
    
    May 2024
52. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.
    PubMed    
    
    
    
53. GUAGLIARDO SAJ, Kracalik I, Carter RJ, Braden C, et al
    Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:460-466.
    PubMed     Abstract available
    
    
    
54. GEIGER K, Stehling-Ariza T, Bigouette JP, Bennett SD, et al
    Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:441-446.
    PubMed     Abstract available
    
    
    
55. GRESSICK K, Nham A, Filardo TD, Anderson K, et al
    Measles Outbreak Associated with a Migrant Shelter - Chicago, Illinois, February-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:424-429.
    PubMed     Abstract available
    
    
    April 2024
56. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    PubMed     Abstract available
    
    
    
57. KALLAY R, Doshi RH, Muhoza P, Choi MJ, et al
    Use of Ebola Vaccines - Worldwide, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:360-364.
    PubMed     Abstract available
    
    
    
58. COLLINS JP, Crowe SJ, Ortega-Sanchez IR, Bahta L, et al
    Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged >/=10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:345-350.
    PubMed     Abstract available
    
    
    
59. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    PubMed     Abstract available
    
    
    
60. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    PubMed     Abstract available
    
    
    
61. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    PubMed     Abstract available
    
    
    
62. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    PubMed     Abstract available
    
    
    
63. MATHIS AD, Raines K, Masters NB, Filardo TD, et al
    Measles - United States, January 1, 2020-March 28, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:295-300.
    PubMed     Abstract available
    
    
    
64. EL KALACH R, Jones-Jack N, Elam MA, Olorukooba A, et al
    Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
    PubMed     Abstract available
    
    
    March 2024
65. LINK-GELLES R, Rowley EAK, DeSilva MB, Dascomb K, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
    PubMed     Abstract available
    
    
    
66. THOMAS CM, Hartley A, Schmitz A, Reid HD, et al
    Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels - United States, May 2022-April 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:260-264.
    PubMed     Abstract available
    
    
    
67. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    PubMed     Abstract available
    
    
    February 2024
68. ZHU S, Quint J, Leon TM, Sun M, et al
    Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:175-179.
    PubMed     Abstract available
    
    
    
69. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    PubMed     Abstract available
    
    
    
70. FRUTOS AM, Price AM, Harker E, Reeves EL, et al
    Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
    PubMed     Abstract available
    
    
    
71. OU AC, Zimmerman LA, Alexander JP Jr, Crowcroft NS, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:162-167.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.